HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 43 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $18,000 | – | 15,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 100,089 | $114,101,000 | 0.42% |
| Ikarian Capital, LLC | 553,273 | $630,000 | 0.09% |
| Aristides Capital LLC | 49,496 | $56,000 | 0.03% |
| McAdam, LLC | 62,168 | $71,000 | 0.01% |
| Virtu Financial LLC | 49,959 | $57,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 20,479 | $23,000 | 0.00% |
| GSA CAPITAL PARTNERS LLP | 20,556 | $23,000 | 0.00% |
| JGP Wealth Management, LLC | 15,000 | $18,000 | 0.00% |
| Amplius Wealth Advisors, LLC | 10,000 | $11,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 55,599 | $63,000 | 0.00% |